Telecommuting will likely continue being popular in 2021.
And the recent $27 billion deal between Salesforce.com and Slack Technologies proves there's still a ton of on-trend growth potential here.
But Andrew doesn't want you to jump on the bandwagon because he's got an even better way to cash in on this scenario...
For most of December, Tom’s Money Calendar is showing between 49 and 151 bullish trading opportunities every day.
That’s a lot of green! And Tom’s picked out one of the best of these dozens of opportunities.
Making this move could have you in the money before mid-January….
Like just about everything else this year, Black Friday, today, is shaping up to look mighty different. Lots of retailers are coming forward to announce their annual "game plan," but some outfits just plain didn't open up on Thanksgiving yesterday.
Plenty of retailers - Walmart, Target, Best Buy, Dick's Sporting Goods, Bed Bath & Beyond - jump to mind.
Now, some companies said they did it for safety reasons; the coronavirus pandemic is as bad as it's ever been in many places, making packed aisles a dicey proposition. Other retailers say they were rewarding employees that have had to go "above and beyond" over the past year.
The "traditional" ways traders have cashed in on Black Friday in the past aren't necessarily going to work here in 2020.
After months of speculation, Tesla has officially carved out a spot on the S&P 500.
For a publicly traded company, it's the ultimate achievement.
The S&P 500’s up rather nicely, hitting an all-time closing high, ever since Pfizer and Moderna announced their COVID-19 vaccine news.
But not everyone has yet caught on to all this “pent-up demand” and all the profit opportunities it offers.
Take a look….
It's safe to assume that recovery from the pandemic will impact stocks one way or another.
And as "unique" as this year's been, we can still use Tom Gentile's Money Calendar to draw some conclusions and make predictions about what they're likely to do in the year ahead to help you make some money...
China’s recently adopted an anti-innovation stance with strict implications on its businesses, such as e-commerce giant Alibaba.
But that does NOT mean to dump Alibaba shares.
Instead, Bill Patalon will have us cashing in on this “one-stock wealth machine” no matter what China does next….
The anticipation is palpable... and building fast. We've had three reports on extremely effective upcoming coronavirus vaccines, and each report practically blows the last one out of the water.
First we heard preliminary reports that Pfizer and BioNTech's revolutionary messenger RNA (mRNA) coronavirus vaccine was 90% effective. That was great... until yesterday morning, when the biotechs got back in touch to say the real figure was something closer to 95%. And in the middle, we've heard from Moderna, which is reporting its mRNA vaccine is 94.5% effective.
Every time, stocks have taken off like a shot at the news; vaccines have helped push the Dow back above its February 2020 highs.
Here's the thing... setting aside the six vaccines The New York Times reports are in limited use in China and Russia - about which there are many unanswered questions - there are at least nine more coronavirus vaccines deep in phase 3, large-scale efficacy trials.
And there are no less than 55 more candidates in earlier, phase 1 and 2 trials. Some of these vaccine candidates won't advance, but others almost certainly will - two have already.
That all this has happened in less than a year is an "Apollo moonshot"-like scientific achievement. But that's also a whole lot of concentrated upside potential that could flood the markets and push stocks to almost unthinkable highs.
So I asked Money Morning Chief Investment Strategist Shah Gilani what it all means for us investors...
With so much focus on stocks and vaccines, people have overlooked the fact that we’ve somehow got a big, unexpected housing boom on our hands.
And Andrew’s housing play could be one of your top profit generators in 2021….
Our Andrew Keene likes to stick to a routine, like the seven stocks he trades every weekday before breakfast.
So today, he’s switching it up and bringing you a list of the six stocks you should stay far, far away from, no matter how popular they’ve been… .
Thanks to this week’s Vaccine Jump, nearly every segment of the market was in the green except one: the big “Pandemic Stocks” like Zoom, Clorox, Peloton, and the like.
While these “Pandemic Stocks” will naturally be marginalized once normality returns, it’s not happening anytime soon.
So don’t run with the crowd on this because these emotionally-driven selloffs are handing us a rare profit opportunity….
Pfizer's recent news that their COVID-19 vaccine is 90% effective sent the market (and Pfizer's stock) soaring.
And while those who had already invested in the stock have made a nice return, Tom's going to show you the quick and easy way to almost quadruple your money on it...
The markets have gone ballistic on positive news of a COVID-19 vaccine, but investors are buying in all the wrong places.
Here are the best COVID-18 vaccine stocks to buy…
The bulls are nearly everything we look in the market.
While a couple of things are currently driving the markets higher, one "driver" in particular is pointing at a trade that's too good to pass up.
Today, Tom's going to show you exactly how to make some easy money on it...
Tom has sifted through and narrowed down the biggest moneymaking stocks to play in this post-election profit plan….
